Verified peer comparison
Verastem vs Foghorn Therapeutics Financial Comparison
Direct answer
Verastem and Foghorn Therapeutics are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Verastem email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Verastem Revenue
- 30,914,000 USD
- Foghorn Therapeutics Revenue
- 30,909,000 USD
- Verastem Operating income
- -170,129,000 USD
- Foghorn Therapeutics Operating income
- -82,107,000 USD